Biofarm (LTS:0HTH) Institutional Ownership : 1.92% (As of May. 19, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Biofarm Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biofarm's institutional ownership is 1.92%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biofarm's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biofarm's Float Percentage Of Total Shares Outstanding is 0.00%.

Biofarm Institutional Ownership Historical Data

The historical data trend for Biofarm's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Institutional Ownership Chart

Biofarm Historical Data

The historical data trend for Biofarm can be seen below:

	2014-10-31	2014-11-30	2014-12-31	2015-01-31	2015-02-28	2015-03-31	2015-04-30	2015-05-31	2015-06-30	2015-07-31
Institutional Ownership	19.23	19.23	2.14	2.14	2.14	2.14	2.14	2.14	1.92	1.92

Biofarm Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Biofarm (LTS:0HTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (LTS:0HTH) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

BIO:Romania

Address

99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website

https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.

Biofarm (LTS:0HTH) Headlines

No Headlines